RS51293B - Derivati tetrahidrohinolina - Google Patents

Derivati tetrahidrohinolina

Info

Publication number
RS51293B
RS51293B YUP-2005/0457A YUP20050457A RS51293B RS 51293 B RS51293 B RS 51293B YU P20050457 A YUP20050457 A YU P20050457A RS 51293 B RS51293 B RS 51293B
Authority
RS
Serbia
Prior art keywords
alkoxy
alkylamino
heterocycloalkyl
amino
alkylaminocarbonyl
Prior art date
Application number
YUP-2005/0457A
Other languages
English (en)
Inventor
Cornelis Marius Timmers
Willem Frederik Johan Karstens
Original Assignee
N.V. Organon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by N.V. Organon filed Critical N.V. Organon
Publication of RS20050457A publication Critical patent/RS20050457A/sr
Publication of RS51293B publication Critical patent/RS51293B/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C07D215/44—Nitrogen atoms attached in position 4 with aryl radicals attached to said nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Derivat tetrahidrohinolina prema Formuli I,ili njegova farmaceutski prihvatljiva so, naznačen time, što: R1 i R2 su H ili Me;R3 je H, hidroksi, (1-4C)alkoksi, (di)(1-4C)alkilamino(2-4C)alkoksi ili (2-6C)heterocikloalkil(2-4C)alkoksi; R4 je H, OH, (1-4C)alkoksi ili R7; R5 je H, OH, (1-4C)alkoksi ili R7;pod uslovom da ako R4 jeH, tada R5 nije H, OH ili (1-4C)alkoksi, a ukoliko R5 je H, tada R4 nije H, OH ili (1-4C)alkoksi; R6 je (2-5C)heteroaril, (6C)aril, (3-8C)cikloalkil, (2-6C)heterocikloalkil ili (1-6C)alkil;R7 je amino, (di)(1-4C)alkilamino, (6C)arilkarbonilamino, (6C)arilkarboniloksi, (2-5C)heteroarilkarbonilamino, (2-5C)heteroarilkarboniloksi, R8-(2-4C)alkilamino, R8-(2-4C)alkoksi, R9-metilamino ili R9-metoksi; R8 je hidroksi, amino, (1-4C)alkoksi, (di)-(1-4C)alkilamino, (2-6C)heterociklo-alkil, (2-6C)heterocikloalkilkarbonilamino, (di)(1 -4C)alkilaminokarbonil-amino, (1-4C)alkoksikarbonilamino, iR9 je aminokarbonil, (di)(1-4C)alkilaminokarbonil, (2-5C)heteroaril ili (6C)aril.Prijava sadrži još 13 patentnih zahteva.
YUP-2005/0457A 2002-12-20 2003-12-16 Derivati tetrahidrohinolina RS51293B (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43504002P 2002-12-20 2002-12-20
EP02102866 2002-12-20
PCT/EP2003/051025 WO2004056780A2 (en) 2002-12-20 2003-12-16 Tetrahydroquinoline derivatives

Publications (2)

Publication Number Publication Date
RS20050457A RS20050457A (en) 2007-08-03
RS51293B true RS51293B (sr) 2010-12-31

Family

ID=39311811

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-2005/0457A RS51293B (sr) 2002-12-20 2003-12-16 Derivati tetrahidrohinolina

Country Status (18)

Country Link
US (1) US7858794B2 (sr)
EP (1) EP1578726B1 (sr)
JP (1) JP4545001B2 (sr)
AR (1) AR042630A1 (sr)
AT (1) ATE423771T1 (sr)
AU (1) AU2003298363B2 (sr)
BR (1) BR0317518A (sr)
CA (1) CA2508952C (sr)
CL (1) CL2003002685A1 (sr)
ES (1) ES2321830T3 (sr)
NZ (1) NZ540578A (sr)
PE (1) PE20040928A1 (sr)
PL (1) PL377318A1 (sr)
RS (1) RS51293B (sr)
RU (1) RU2328488C2 (sr)
TW (1) TWI306855B (sr)
UA (1) UA81442C2 (sr)
WO (1) WO2004056780A2 (sr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4523273B2 (ja) * 2001-07-02 2010-08-11 ナームローゼ・フエンノートチヤツプ・オルガノン テトラヒドロキノリン誘導体
TWI322012B (en) * 2002-12-20 2010-03-21 Organon Nv Tetrahydroquinoline derivatives
TWI306855B (en) 2002-12-20 2009-03-01 Organon Nv Tetrahydroquinoline derivatives
US7691848B2 (en) 2005-03-02 2010-04-06 Wyeth Pyrrolobenzodiazepine arylcarboxamides and derivatives thereof as follicle-stimulating hormone receptor antagonists
CN101213197A (zh) 2005-05-12 2008-07-02 惠氏公司 作为促卵泡激素受体(fsh－r)拮抗剂的吡咯并苯并二氮杂䓬以及杂环甲酰胺衍生物
MX2007015643A (es) * 2005-06-09 2008-02-15 Wyeth Corp Pirrolobenzodiazepinpiridincarboxamidas y derivados como antagonistas de receptor de hormona estimulante del foliculo.
US8106190B2 (en) 2005-11-30 2012-01-31 Astellas Pharma Inc. 2-aminobenzamide derivatives
EP1956016A1 (en) * 2006-12-15 2008-08-13 Bayer Schering Pharma Aktiengesellschaft Bicyclic acyltryptophanols
WO2008071455A1 (en) * 2006-12-15 2008-06-19 Bayer Schering Pharma Aktiengesellschaft Bicyclic acyltryptophanols
GB0705656D0 (en) * 2007-03-23 2007-05-02 Addex Pharmaceuticals Sa Novel compounds E1
TW200918058A (en) * 2007-08-31 2009-05-01 Organon Nv TSH receptor antagonizing tetrahydroquinoline compounds
US8071587B2 (en) * 2009-05-27 2011-12-06 N. V. Organon (Dihydro)imidazoiso[5,1-A]quinolines
US8431564B2 (en) 2009-07-29 2013-04-30 Merck Sharp & Dohme B.V. Ring-annulated dihydropyrrolo[2,1-α]isoquinolines
TW201116531A (en) * 2009-07-29 2011-05-16 Organon Nv Ring-annulated dihydropyrrolo[2,1-a]isoquinolines
WO2017192847A1 (en) * 2016-05-04 2017-11-09 University Of Cincinnati Female fertility therapies

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2686182A (en) 1950-12-07 1954-08-10 Basf Ag O-hydroxy-dihydro-quinoline carboxylic acids
ATE86484T1 (de) 1987-08-08 1993-03-15 Akzo Nv Kontrazeptives implantat.
DK0800519T3 (da) * 1994-12-22 2004-03-01 Ligand Pharm Inc Steroidreceptormodulatorforbindelser og fremgangsmåder
US6235755B1 (en) * 1998-08-07 2001-05-22 Applied Research Systems Ars Holding N.A. FSH mimetics for the treatment of infertility
US6200963B1 (en) * 1999-03-31 2001-03-13 American Home Products Corporation Aryl sulfonic acids as FSH antagonists
JP4523273B2 (ja) * 2001-07-02 2010-08-11 ナームローゼ・フエンノートチヤツプ・オルガノン テトラヒドロキノリン誘導体
TWI306855B (en) 2002-12-20 2009-03-01 Organon Nv Tetrahydroquinoline derivatives
TWI322012B (en) * 2002-12-20 2010-03-21 Organon Nv Tetrahydroquinoline derivatives
TW592127U (en) * 2003-05-19 2004-06-11 Tatung Co Network-type physiology monitoring device

Also Published As

Publication number Publication date
AU2003298363B2 (en) 2009-09-24
CA2508952A1 (en) 2004-07-08
JP2006512347A (ja) 2006-04-13
ATE423771T1 (de) 2009-03-15
CA2508952C (en) 2011-09-13
EP1578726B1 (en) 2009-02-25
PE20040928A1 (es) 2004-12-25
WO2004056780A3 (en) 2004-08-05
CL2003002685A1 (es) 2005-04-08
TW200418800A (en) 2004-10-01
PL377318A1 (pl) 2006-01-23
BR0317518A (pt) 2005-11-16
WO2004056780A2 (en) 2004-07-08
RU2328488C2 (ru) 2008-07-10
RU2005122946A (ru) 2005-12-20
RS20050457A (en) 2007-08-03
NZ540578A (en) 2006-12-22
JP4545001B2 (ja) 2010-09-15
AR042630A1 (es) 2005-06-29
US7858794B2 (en) 2010-12-28
US20060142334A1 (en) 2006-06-29
EP1578726A2 (en) 2005-09-28
AU2003298363A1 (en) 2004-07-14
UA81442C2 (en) 2008-01-10
ES2321830T3 (es) 2009-06-12
TWI306855B (en) 2009-03-01

Similar Documents

Publication Publication Date Title
RS51293B (sr) Derivati tetrahidrohinolina
RS51196B (sr) Derivati tetrahidrohinolina
RS52953B (sr) Piridopirimidinonski inhibitori pi3 kalfa
ATE264852T1 (de) Chinolinderivate als antibakterielle mittel
RS51795B (sr) 2-amino-7,8-dihidro-6h-pirido[4,3-d]pirimidin-5-oni, postupak za njihovo dobijanje i farmaceutske kompozicije koje ih sadrže
NO950297L (no) Prolinamidderivater
CA2222377A1 (fr) Compositions comprenant un derive de dibenzoylmethane, un derive de 1,3,5-triazine et un compose amide et utilisations
CA2295106A1 (en) 3-anilino-2-cycloalkenone derivatives
AU3922097A (en) Azabicyclo (3.2.0) heptane derivatives
EP0911328A4 (sr)
IL107627A (en) Pharmaceutical compositions containing 3-substituted-2-amino-4- (hetero) arylpyrano (iso) quinoline derivatives, some new such derivatives and their preparation
AU2901395A (en) Phosphinic acid derivatives
AU647481B2 (en) Hexahydroazepine derivatives, a process for their preparation and pharmaceutical compositions containing them
ATE132142T1 (de) Salicylsäurederivate
ES8404976A1 (es) Procedimiento para preparar nuevos derivados de encefalina.
EP1404652A4 (en) NEW ALKALOID DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME
AU1121195A (en) Chroman derivatives
AU5715894A (en) Methotrexate derivative
CO5590903A2 (es) Derivados de tetrahidroquinolina
CA2216288A1 (en) Uracilic hydroquinone derivatives as type iv allergy inhibitors
ECSP055870A (es) Derivados de tetrahidroquinolina
ATE497497T1 (de) 1,2,4-triazolderivat, verfahren zu dessenherstellung, und dieses enthaltende pharmazeutische zusammensetzung
CA2356114A1 (en) Fungicide mixtures which are based on derivatives of morpholine or piperidine and derivatives of oxime ether
HK1032235A1 (en) 1-aza-2-alkyl-6-aryl-cycloalkane compounds, a process for their preparation and pharmaceutical compositions containing them
AU2002339174A1 (en) Light emitting device and compounds for use therein